rTMS Combined With Aerobic Exercise for Older Adults With Mild Cognitive Impairment and Comorbid Depression

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age65-90
SponsorCheng-Hsin General Hospital

About this trial

This study aims to evaluate the effects of repetitive transcranial magnetic stimulation (rTMS) and aerobic exercise on cognitive function and mental health in older adults with mild cognitive impairment (MCI) and comorbid depression. Forty-five participants will be randomly assigned to one of three groups: (1) rTMS alone, (2) rTMS combined with stationary cycling exercise, or (3) sham rTMS combined with stationary cycling exercise. Participants will receive 20 intervention sessions over a 5-week period (4 sessions per week). Outcomes, including cognitive function, depressive symptoms, sleep quality, life satisfaction, self-efficacy, and gait performance, will be assessed at baseline, immediately after completion of the 5-week intervention, and at a 1-month follow-up. The findings may contribute to the development of evidence-based, non-pharmacological interventions for improving cognitive and mental health outcomes in older adults with MCI and comorbid depression.

Eligibility criteria

Qualifiers

Aged 65 to 90 years.

Diagnosed with mild cognitive impairment (MCI) according to established clinical criteria.

Presence of depressive symptoms as determined by clinical assessment and Beck Depression Inventory-II (BDI-II).

Able to communicate and follow study instructions.

Disqualifiers

Diagnosis of dementia.

History of epilepsy or seizure disorder.

Presence of metallic implants, pacemakers, cochlear implants, or other contraindications to transcranial magnetic stimulation.

Major neurological disorders, including stroke, Parkinson's disease, traumatic brain injury, or other neurodegenerative diseases.

Trial design

Treatments tested in this trial

  • Repetitive Transcranial Magnetic Stimulation
  • Aerobic Exercise
  • Sham Repetitive Transcranial Magnetic Stimulation

Treatment groups

45 Participants
are divided into 3 treatment groups

Sponsors and collaborators